Achievable logoAchievable logo
USMLE/1
Sign in
Sign up
Purchase
Textbook
Support
How it works
Resources
Exam catalog
Mountain with a flag at the peak
Textbook
Introduction
1. Anatomy
2. Microbiology
3. Physiology
4. Pathology
5. Pharmacology
6. Immunology
7. Biochemistry
8. Cell and molecular biology
9. Biostatistics and epidemiology
9.1 Measure of disease frequency
9.2 Measures of health status
9.3 Reportable diseases
9.4 Variables and distributions
9.5 Standard deviation and confidence intervals
9.6 Measures of association
9.7 Types of study design
9.8 Bias
9.9 Hypothesis testing
9.10 Sensitivity, specificity and predictive values
9.11 Phases of drug approval
9.12 Doctor patient relationships, ethics and decision-making capacity
9.13 Additional information
10. Genetics
11. Behavioral science
Wrapping up
Achievable logoAchievable logo
9.7 Types of study design
Achievable USMLE/1
9. Biostatistics and epidemiology

Types of study design

6 min read
Font
Discuss
Share
Feedback

Study designs may be observational or interventional/experimental. This video and the chapter below introduce the main types:

Observational

  • Case series
  • Case control
  • Cross sectional
  • Cohort or prospective
  • Historical cohort

Experimental

  • Randomized controlled trials or RCT
  • Non randomized trials
  • Sequential trials
  • Studies with no control groups

Meta-analysis is also a type of study design.

  1. Case series: A case series describes interesting characteristics observed in a group of patients. It’s often used to report a cluster of rare cases or cases with unusual presentations.

    For example, a hospital may report a case series of Coronavirus infections in 12 pediatric patients presenting with Kawasaki syndrome.

    Typically, case series do not have a control group. They may also be used to describe different treatment approaches used in different patients and compare outcomes. Case series often serve as a starting point for more detailed studies.

  2. Case-control study: A case-control study compares two groups:

    • Cases: individuals who have a particular disease or outcome of interest
    • Controls: individuals without the disease or outcome of interest

    The groups are compared for the presence or absence of particular risk factors. This design is retrospective: you select people based on disease status and then look back in time to identify prior exposures.

    For example, to study whether cigarette smoking is associated with heart disease, you select one group with heart disease and another group without heart disease. Then you look back and collect smoking histories in both groups and compare them. You may also identify other risk factors associated with heart disease when comparing the two groups.

    The two groups should be comparable. For example, you can’t compare risk factors for ischemic heart disease between adults and children. However, you can compare risk factors for ischemic heart disease between two states or countries.

    Case-control studies are analyzed using the odds ratio. They can establish an association between a risk factor and an outcome/disease, but they do not establish causality (you can’t conclude that a risk factor caused the outcome). Incidence and prevalence cannot be calculated from a case-control study.

    Case-control studies are useful for:

    • Rare outcomes
    • Outcomes with long latent periods

    If the exposure is rare, a case-control study is not useful.

    Cross sectional or prevalence studies: In a cross sectional study, data is collected from the study group at a single point in time rather than over a period of time. It measures both the outcome and the exposure(s) in a population and may examine their association.

    Examples include:

    • A population survey
    • Calculating the percentage of abnormal glucose tolerance tests among adults attending a clinic on Jan 1, 2020
    • Estimating the prevalence of HIV among 300 patients who attended an STI clinic

    Prevalence of a disease and odds ratio can be calculated from cross sectional studies. Cross sectional studies are relatively fast and inexpensive to conduct, but they cannot establish causal relationships.

  3. Cohort studies: Cohort studies are prospective studies in which groups are selected based on the presence or absence of a risk factor (exposure) and then followed over time to observe outcomes. Cohort studies are of the following types:

    i) Typical or classical or prospective cohort studies: In this type of cohort study, all data are collected prospectively. Subjects in both groups are assessed regularly for outcomes and for the natural history of the disease and/or disease process. This design is time consuming and costly.

    ii) Historical or retrospective cohort studies: In this type of cohort study, researchers use existing records (for example, hospital or health records) to identify past exposures and then determine outcomes.

    This design is sometimes confused with a case-control study. To tell them apart, focus on how participants are selected:

    • Cohort study: groups are defined by exposure (risk factor) status, then outcomes are assessed
    • Case-control study: groups are defined by outcome (disease) status, then past exposures are assessed

    Although a historical cohort study is less time consuming and less expensive than a classical cohort study, it is less accurate.

    Cohort studies can be used to establish causation because the temporality between exposure and outcome is well defined. If the exposure is rare, a cohort design is an efficient method to study the relation between exposure and outcomes. Cohort studies are not always useful for rare outcomes. Incidence rate can be calculated from a cohort study.

  4. Experimental studies or clinical trials: Experimental studies that involve humans are called clinical trials.

    • Controlled trials: the investigational drug or procedure is compared to a placebo, another drug/treatment, or standard therapy.
    • Uncontrolled trials: there is no control group.

    In a double blind trial, neither the subject nor the researcher knows whether the subject is in the treatment group or the control group. The treatment group receives the experimental drug or intervention, while the control group receives a placebo.

    • If only one party (either the patient or the researcher) is blinded, the study is single blind.
    • A study with no blinding is open.

    The highest possible degree of blinding should be chosen to minimize bias.

    A randomized controlled trial or RCT is a study design that randomly assigns participants to an experimental group or a control group. RCTs are used to study the safety and efficacy of new treatments. An RCT is considered the best study design because it establishes causality with less bias.

What is randomization?

  • The process by which participants in clinical trials are assigned by chance (randomly) to separate groups.
  • Used to negate the effect of confounding factors and bias.
  • Randomization can be stratified according to age, sex etc.

Non-randomized trials do not use randomization and are considered weak studies that are prone to bias.

A sequential clinical trial is a trial in which observations are assessed as they are produced. The total number of participants is not predetermined; it depends on the accumulated results. More subjects are added to the study if the statistical analysis requires it.

In a crossover trial, all patients eventually receive the experimental drug/intervention by exchanging groups. For example, group A gets placebo for the first three months while group B gets drug 1. At the end of 3 months, group A gets drug 1 for another three months while group B gets the placebo.

  1. Meta-analysis: Meta-analysis involves analyzing the results of previous research to derive conclusions about that body of research. Outcomes from a meta-analysis may include a more precise estimate of the effect of a treatment or a risk factor for disease (or other outcomes) than any individual study. An example is the Cochrane review.
All rights reserved ©2016 - 2026 Achievable, Inc.